Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Painkiller study hopes to speed up hospital discharge after surgery

NCT ID NCT02832687

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether giving patients IV acetaminophen (a pain and fever reducer) every 4 hours after gallbladder surgery helps them recover faster and leave the hospital sooner. The trial planned to enroll 88 adults but was terminated early, so the results are limited. The researchers measured pain, nausea, and other factors to see if the drug improved readiness for discharge.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
acetaminophen (also known as Ofirmev)
What this could lead to
If it worked, this could point toward a way to help patients leave the hospital sooner after surgery by reducing pain and nausea.
What could go wrong
The study was terminated early, so we don't have clear results. It was also a small pilot study, so any findings would need much more testing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

88 people

The number who actually took part.

Started

Jun 2017

Finished

Dec 2020

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Undergoing ambulatory laparoscopic cholecystectomy. * American Society of Anesthesiologists physical status 1, 2 or 3.- Exclusion Criteria - * Cognitively impaired (by history) and unable or unwilling to consent * Chronic steroid or opioid user (as prescribed for a chronic systemic illness) * Parturient or nursing mother. Patients who have been informed by a physician that they have liver or kidney disease

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Recovery following cholecystectomy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • New Jersey Medical School

    Newark, New Jersey, 07103, United States

  • New York Methodist Hospital

    Brooklyn, New York, 11215, United States

  • University Hospital

    Newark, New Jersey, 07103, United States